The present invention relates to an apparatus for precisely positioning a medical instrument with respect to a patient and, more particularly, to a positioning system for precisely and repeatably positioning a transcranial magnetic stimulation coil at the treatment position of a patient.
Current methods of placement and positioning of coils for Transcranial Magnetic Stimulation (TMS) studies are either manual methods or approaches designed for research that require expensive and complex imaging or computational systems to determine three dimensional spatial coordinates for positioning reference. These techniques have severe clinical limitations. The manual methods do not provide a convenient means for repeated and accurate placement, while the three dimensional spatial methods based on imaging modalities are expensive, time consuming, and not conducive to clinical use. A positioning technique for clinical use is desired that provides a simple way for the operator to perform repeated and accurate coil placement for TMS studies and treatments in a time-efficient and inexpensive manner.
Manual Methods
In accordance with the conventional manual placement and position marking technique, a treatment position on the patient's head or a position used to find a treatment position, such as the patient's motor threshold position (MTP), is determined by moving the coil near a predicted area determined by patient anatomical landmarks until the desired motor response is achieved. The position is marked, for example, with an ink mark on the patient's head. In the case of using the TMS coil for treatment of depression, for example, the TMS therapy position is determined by moving the coil from the MTP along a line in the anterior direction a prescribed distance (a widely accepted distance is 5 cm). The Therapy Position (TXP) is then marked on the patient (e.g., with ink) so it can be easily found in subsequent therapy sessions.
The most common method of localization used for TMS studies is described by George et al. in “Daily Repetitive Transcranial Magnetic Stimulation (rTMS) Improves Mood in Depression,” NeuroReport, Vol. 6, No. 14, October 1995, pp. 1853-1856, and by Pascual-Leone et al. in “Rapid-Rate Transcranial Magnetic Stimulation of Left Dorsolateral Prefrontal Cortex in Drug-Resistant Depression,” The Lancet, Vol. 348, Jul. 27, 1996, pp. 233-237. Simply stated, in these methods the coil is first moved over the area of the left motor cortex until stimulation of the contralateral abductor pollicis brevis muscle (APB) is attained. This position is the motor threshold position (MTP) and is typically located on a line between the left auditory meatus (i.e. ear canal) and the vertex of the head, at a point about ½ to ⅔ of the distance to the vertex. In the case of excitatory stimulation of the left prefrontal cortex for the treatment of depression, for example, the TXP is located by starting at the MTP and moving 5 cm toward the midpoint between the tip of the nose and the nasion (protuberance just above the bridge of the nose). More details of techniques for determining the MTP are also described in U.S. Pat. No. 7,104,947, the contents of which are incorporated herein by reference.
The shortcomings of such manual methods are that precisely determining the line from the MTP to the TXP is difficult, marks applied to the patient that can wash off between treatment sessions are cosmetically undesirable, the coil may not be comfortably held at the TXP throughout a therapy session, and the technique is highly operator dependent and not conducive to repeatable and accurate positioning.
The problem of applying marks to the patient has been addressed in the art by applying a swim cap or similar conformal headgear to the patient and marking the headgear rather than the patient. Of course, this approach requires careful registration of the headgear during subsequent therapy sessions, which is crude, imprecise, and highly operator dependent. Moreover, such an approach still requires accurate coil placement and a mechanism for holding the coil in place.
Complex Imaging/Computational Systems
The Brainsight™ System developed by Rogue Research, Inc. of Montreal, Canada and distributed by Magstim is complex and is designed primarily for research purposes. This system uses diagnostic images from MRI or PET systems to determine the spatial relationship between internal anatomy and external landmarks and then aligns to the external landmark for therapy or other studies requiring accurate localization. While this approach is useful for research purposes, it is highly impractical and complex and is thus not usable in general clinical practice. Moreover, such techniques have generally been used to overlay coordinate systems onto images and not for identifying particular treatment positions for specific therapies.
Robotic Arms for Holding TMS Coils
U.S. Pat. Nos. 6,266,556 and 7,087,008 include descriptions of methods in which a robotic arm is operatively coupled to the TMS coil for positioning the coil with respect to the patient and holding the coil in place during TMS treatment. A similar technique using a robotic arm for coil placement is also disclosed in U.S. Pat. Nos. 6,827,681 and 6,830,544. These patents further disclose a technique for modeling the spatial structure of the patient's brain for determining the proper stimulation position using a stimulation model. While these techniques provide controlled movement and placement of the coil, they are quite expensive and do not provide for repeatable placement of the coil with respect to a particular patient's head in a clinical setting. As a result, the manual and/or complex imaging techniques described above must also be used for placement of the coil with respect to the patient.
Positioning TMS Coils Relative to Fixed Head Position
U.S. Patent Publication No. 2005/0148808 to the present assignee describes a TMS coil positioning system in which the patient's head is fixed and the TMS coil is fixed at a treatment position in the coordinate system of the patient's head. The position in the coordinate system is recorded for use in subsequent clinical sessions. In an exemplary embodiment, the positioner assembly is a mechanical system that supports the weight of the TMS coil and allows the operator to freely move the TMS coil to search for the treatment position and/or the patient's motor threshold position (MTP). Once the MTP is determined, the positioner assembly requires a single adjustment of the magnet position to locate the treatment position (TXP) where the coil is locked in place for the duration of the TMS therapy. By recording the positions of the different adjustable components in the respective coordinate directions of the coordinate system of the patient's head, exact repositioning of the TMS coil for the patient during a subsequent clinical visit is made possible without use of expensive imaging equipment.
The apparatus includes three basic components including (1) a headset assembly that accepts the patient's head and fixes its position, (2) a coil positioner assembly that accepts the headset assembly and holds the headset assembly and the patient's head at a fixed position, controls positioning of the TMS coil within a coordinate system defined about the fixed position, and holds the TMS coil in place at a treatment position during treatment, and (3) an alignment strip applied at a position in registration with an anatomical landmark of the patient including at least one registration mark for aligning the patient's head within the headset assembly. Each of these components working together permit the coil assembly to be located in coordinates with respect to the patient's head such that the treatment may be repeated during a subsequent visit by repeating the coordinates. However, such a system requires the treatment coil to be affixed to the positioning apparatus and the patient's head to remain fixed relative to the apparatus during treatment. A coil positioning system and treatment apparatus is desired that physically separates the functions of supporting the weight of the coil from the alignment function so that the coil can be easily placed or removed and so that the patient can be situated in a range of positions, thereby increasing the patient's comfort and acceptance of the TMS treatment.
Thus, the need for a simple, cost-effective and intuitive way to accurately and repeatably position the coil for TMS therapy in a clinical setting without fixing the patient in one position during treatment has not been met in the prior art. The present invention addresses this need.
The invention addresses the above-mentioned limitations in the prior art through use of a mechanical device that provides simple positioning of the TMS coil relative to the patient's head without requiring the patient to be in one particular position. In particular, the device of the invention repeatably positions a transcranial magnetic stimulation (TMS) coil with respect to a patient to receive treatment. In an exemplary embodiment, the device includes a head support that supports a patient's head, a coil alignment assembly that aligns the TMS coil with the patient's head in a fixed orientation for treatment, and a coil gantry that supports the weight of the TMS coil and is guided by the coil alignment assembly to a treatment location on the patient's head for patient treatment. The coil gantry includes a multi-axis support that allows adjustment of the pitch, roll and yaw of the TMS coil for seating of the TMS coil against the patient's head. The coil gantry may also include a mast that supports a balance arm, where the balance arm has the TMS coil on one end thereof and a counterbalance on another end thereof. In exemplary embodiments, the multi-axis support comprises a ball and socket arrangement.
The device of the invention may further be configured so that the mast is mounted on a mobile console having wheels. In an exemplary embodiment, a display is mounted on the mobile console. The display is adapted to accept inputs from a user (clinician) representing measurements of the pitch, roll and yaw of the TMS coil and position measurements of the patient's head in the coil alignment assembly. The coil gantry may also include at least one release to lock brake that, when released, prohibits movement of the TMS coil in one or more of the pitch, roll, and yaw directions, thus facilitating coil placement.
The device of the invention is configured with respect to a treatment chair adapted to accept the patient and adapted to accept the patient's head in the head support when the patient is seated in the treatment chair. Once the patient is positioned in the treatment chair, the position measurements of the patient's head are taken, and a side pad that is positioned against the patient's head opposite the TMS coil during treatment is pushed up against the patient's head. The combination of the coil and the side pad on opposite sides of the patient's head functions to keep the patient's head relatively still.
The coil alignment assembly of the invention is preferably adapted to take position measurements of the patient's head to facilitate placement of the patient's head from one treatment session to the next. For example, the coil alignment assembly may include a superior oblique angle guide including an angle indicator that indicates an angle of the superior oblique angle guide with respect to the patient's mid-sagittal plane. The coil alignment assembly may also include a pivot arm that supports an anterior/posterior guide that moves in a plane parallel to the patient's anterior/posterior axis and allows the anterior/posterior guide to rotate through a range of superior oblique angles on either side of the mid-sagittal plane of the patient's head, where the angles are measured by the angle indicator of the superior oblique angle guide. In addition, the anterior/posterior guide may support a lateral canthus guide oriented in the patient's superior/inferior direction for aligning with at least one anatomical landmark of the patient's head. The lateral canthus guide may include a scale that indicates a reference position for aligning the patient's head for repeatable positioning of the patient's head from treatment session to treatment session. The lateral canthus guide may alternatively include an alignment laser for alignment with the anatomical landmarks. A coil angle indicator also may be attached to an end of the anterior/posterior guide and include a scale for measuring the angle of the coil with respect to a center location of the anterior/posterior guide.
To facilitate alignment of the patient's head, alignment straps may also be applied at a position in registration with an anatomical landmark of the patient. The alignment straps may, for example, include a registration mark for aligning the patient's head within the coil alignment assembly. The alignment straps are typically applied to the patient's head so as to restrain the patient's head in the nodding and left/right positions. In an exemplary embodiment, the alignment straps are aligned with the patient's nose and affixed to the patient's forehead to define a mid-sagittal plane. A crown strap wraps from the back of the patient's head over a crown of the patient's head to an alignment position on a lateral strap that wraps around the respective sides of the patient's head and that is attached to the head support so as to center the patient's face in the left/right direction in the mid-sagittal plane.
The above and other features and advantages will become apparent to those skilled in the art based on the following detailed description of the drawing figures, of which:
A detailed description of an illustrative embodiment of the present invention will now be described with reference to
A TMS system is a computerized electromechanical instrument that produces and delivers brief duration rapidly alternating, or pulsed, magnetic fields to induce electrical currents directed at localized regions of the cortex. The present invention is designed to position a TMS coil of the TMS system for treatment of central nervous system disease states using TMS therapies. While an exemplary embodiment of the invention is described with respect to the excitatory stimulation of the left prefrontal cortex for the treatment of depression, those skilled in the art will appreciate that the apparatus and techniques of the invention may be used to apply TMS therapies to many other central nervous system targets for the treatment of numerous other central nervous system diseases. For example, the positioning device of the invention may be used to position the TMS over the right prefrontal cortex of a patient for low frequency inhibitory stimulation in the treatment of depression. Those skilled in the art will further appreciate that the positioning device of the invention also may be used to position a TMS coil for the treatment of: epilepsy (above seizure locus), schizophrenia (at Wernicke's Area), Parkinson's Disease, Tourette's Syndrome, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), Alzheimer's Disease, Attention Deficit/Hyperactivity Disorder, obesity, bipolar disorder/mania, anxiety disorders (panic disorder with and without agoraphobia, social phobia a.k.a. Social Anxiety Disorder, Acute Stress Disorder, Generalized Anxiety Disorder), Post-traumatic Stress Disorder (one of the anxiety disorders in DSM), obsessive compulsive disorder (one of the anxiety disorders in DSM), pain (migraine, trigeminal neuralgia), chronic pain disorders (including neuropathic pain such as pain due to diabetic neuropathy, post-herpetic neuralgia, and idiopathic pain disorders such as fibromyalgia and regional myofascial pain syndromes), rehabilitation following stroke (neuro plasticity induction), tinnitus, stimulation of implanted neurons to facilitate integration, substance-related disorders (dependence and abuse and withdrawal diagnoses for alcohol, cocaine, amphetamine, caffeine, nicotine, cannabis), spinal cord injury and regeneration/rehabilitation, head injury, sleep deprivation reversal (DARPA), primary sleep disorders (primary insomnia, primary hypersomnia, circadian rhythm sleep disorder), cognitive enhancements, dementias, premenstrual dysphoric disorder (PMS), Drug delivery systems (changing the cell membrane permeability to a drug), induction of protein synthesis (induction of transcription and translation), stuttering, aphasia, dysphagia, essential tremor, Magnetic Seizure Therapy (MST), and other central nervous system disorders that may treated by the application of a magnetic field at particular locations in the brain. Of course, in each case, the treatment positions may vary; however, in each case the positioning device of the invention is useful in finding the treatment location in a repeatable manner and holding the TMS coil in the treatment position during therapy.
System Configuration
As illustrated in
Mobile Console 10 is an enclosed module that forms the TMS system's wheeled base and integrates various subsystems into a single package. It houses a processor module and a power module (not shown) and supports the mast 12 that, in turn, supports coil gantry 14 that supports coil 16 and the display arm 18 that supports the display 20. The Mobile Console 10 is the central workstation for a TMS procedure and is the main control center for all TMS system subsystems.
System Software—A computer software application running on the processor module (not shown) provides a TMS system graphical user interface on display 20 and incorporates work flow management to guide the system user (clinician) through a TMS procedure, and also supervises and controls various subsystems. The TMS System Software controls all internal system functions, monitors system status to ensure safe operation and provides the user with a graphical means to manage the course of TMS treatment. User interaction with the System Software is provided via touch screen display 20 including touch-activated images of alphanumeric keys and buttons for user interaction with the system. The display 20 provides graphic representations of system activity, messages, and alarms. Interactive buttons, fields, and images also are displayed that enable the user to direct and interact with system functions, such as entering data, starting and stopping treatment, and running diagnostics.
Coil 16 includes an enclosed electromagnet that is mounted to the coil gantry 14 which supports its weight as it is placed against the patient's head. The coil 16 generates and applies a pulsed magnetic field to tissue immediately beneath the coil 16 in response to commands from the processor and power modules. The magnetic field penetrates the skull and reaches the patient's cortex when the coil is placed against the patient's head. This pulsed field is controlled by the TMS system power module and system software in response to user settings. The coil gantry 14 includes a lateral translation table within the Mobile Console 10, a vertical mast 12, a balance arm with counterbalance 22, and a halo assembly 24 that connects to the coil 16 as shown in
Treatment Chair 28 is an operator controlled, adjustable chair that positions the patient comfortably at a desirable height and angle for TMS treatment and provides lumbar support. The treatment chair 28 is adjustable to accommodate the patient in a comfortable reclining position such that the patient's coronal plane is approximately 30°-75° from horizontal during treatment and includes a separate attachment for the chair that provides adjustable head support and includes a guidance apparatus in accordance with the present invention to aid in positioning the coil 16 against the patient's head. The treatment chair 28 is an electromechanical device on which the patient is seated during treatment with the TMS system and resembles the type of chair used in dental treatment environments. The treatment chair 28 may include a pushbutton control unit (wired or wireless) that adjusts the chair height, the patient's reclining position, and the patient's leg support. The treatment chair 28 also may include a substantial base for overall stability and a built-in adjustable lumbar support cushion for patient comfort. The seat tilt feature helps lift the patient's seat to avoid patient slouching.
Head Support and Coil Alignment Unit 30 is an electro-mechanical device in accordance with the present invention that comprises several parts that are designed to provide maximum patient comfort and reliable coil position measurement of the patient's motor threshold (MT) location and/or TMS treatment location. The Head Support and Coil Alignment Unit 30 aligns the patient's head and holds the head in place relative to the coil during TMS treatment. The individual parts of the Head Support and Coil Alignment Unit 30 are identified in
As shown in
As shown in
The Head Support and Coil Alignment Unit 30 also includes a superior oblique angle (SOA) guide 48 including an angle indicator 49 (
A coil angle indicator 64 includes a flat curved scale that is attached to the end of the AP guide 54. Coil angle indicator 64 enables the user to record the position of the coil 16 up to 20° to the left or right of the center location. A vertical alignment knob 66 (
The Head Support and Coil Alignment Unit 30 also may include a head cushion liner 68 that includes a thin, tissue-like disposable cover that is placed on the head cushion 50 as a hygienic barrier for each patient session. The Head Support and Coil Alignment Unit 30 also offers the patient further comfort through the use of the side pad 44 that may be set up both on the left or the right side of the patient's head. The side pad 44 is a replaceable foam pad that is mounted on the side pad bracket 46. During treatment, the side pad 44 is covered by a disposable side pad liner 70 that is a thin, tissue-like disposable cover that is placed on the side pad 44 as a hygiene barrier for each patient session.
Patient Positioning Procedure
For effective treatment, the patient is seated comfortably so as to be properly aligned with the TMS system. The patient is positioned at a height that provides the operator with comfortable access for positioning the TMS coil 16. The steps for finding the correct patient position using the components illustrated in
Prior to treatment, the patient must remove certain objects before activating the TMS system, including hearing aids, eyeglasses, or metal hairclips. Loose metallic objects are especially prohibited near the coil 16. Prior to seating the patient, a fresh head cushion liner 68 is placed over the head support 50 and a fresh side pad liner 70 is placed over the side pad cushion 44. The side pad positioning arm 46 is unlocked by pushing or pulling the metal locking bar to bring it to an equal distance on both sides from the Head Support and Coil Alignment Unit 30. The side pad positioning arm 46 is positioned to a vertical position and the AP arm 52 is positioned to “0” and at the “0” position on the left superior oblique angle guide 48. The LC dial is set to “0” using LC knob 56.
Once the patient is ready, the patient is correctly positioned to sit in the Treatment Chair 28. Using a chair controller 72 (
The patient is then placed in position for a determination of the motor threshold (MT) position. First, the AP guide 54 is rotated to the patient's left side until it reaches a mechanical stop. The LC pointer 74 is attached to the AP guide 54 and the user ensures that the LC pointer 74 is close to, but not touching, the patient's head as shown in
Next, alignment straps 76 are placed on the patient's forehead just above the eyebrow line and the pointer 78 (
The patient's measurements for the LC and head support positions (vertical alignment, articulation setting) and top strap position setting are recorded at the appropriate times using the touch display 20 (
Once the patient is positioned and the straps are placed on the patient's head as illustrated in
The motor threshold (MT) location of the patient for treatment or as part of the screening process is located for each new patient by grasping the coil handle 40 and pressing and holding the brake release button 42. The user starts searching on a mid-coronal plane, which falls at the level from the top of the subject's left ear to the vertex (top) of the head. To start, the user positions the coil 16 so that the tab 86 is just above the patient's ear (
For automatic MT location, the patient is instructed to hold his or her right hand in a position that enables the user to observe a twitch in the right thumb (abductor pollicis brevis muscle). The coil assembly 16 is moved to search for the optimal site of the right motor cortex region of the brain. This will cause movement of the right APB muscle, which will produce a visible twitch of the patient's right thumb. The search starts on a mid-coronal plane, which falls at the level from the top of the subject's left ear to the vertex of the head. To start, the coil 16 is positioned so that the edge of the coil 16 above the handle 40 is just above the patient's ear. The brake release button 42 on the coil handle 40 is pressed and the coil 16 is moved to a possible MT location. The brake release button 42 is pressed to set the brake. To begin locating the optimal stimulation site, a slider 92 in the lower left-hand side of the touch screen display 20 is used to gradually increase the machine power output at a suprathreshold range, which is generally between 1.00 and 1.10 Standard Motor Threshold (SMT) units. The default starting power is, for example, 0.68 SMT units. The power output is increased or decreased as necessary to achieve a reliable observed thumb and forefinger twitch when the coil 16 is positioned over the optimal location.
Once the coil 16 is placed, the START button 94 on the touch-screen 20 is pressed to cause the system to automatically generate a pulse every 3-10 seconds. If the patient's thumb twitch is not observed, the coil 16 is moved to a different location on the patient's head or the MT level is increased in one of three ways:
The user continues the search for the patient's MT location using these steps until the optimal location is determined to isolate the (APB) thumb muscle. Once the MT location has been identified, the AP guide 54 is moved up to the coil 16 aligning the coil angle guide 64 to the center line on the side of the coil (
Those skilled in the art will appreciate that once the patient's head is aligned in the Head Support and Coil Alignment Unit 30 that the side pad mechanism 46 pushed up against the side of the patient's head opposite the TMS coil assembly 16 prevents side-to-side movement of the patient's head when a small force is applied to the other side of the patient's head during the seating of the TMS coil assembly 16 on the patient's head. As illustrated in
Since the procedure is highly repeatable, the recorded positions (lateral canthus position, left superior oblique angle, anterior/posterior position, and coil rotation position) in the patient's coordinates may be used to allow a patient to be treated easily on other systems that employ the same positioning and/or coordinate systems.
Those skilled in the art also will readily appreciate that many additional modifications are possible in the exemplary embodiment without materially departing from the novel teachings and advantages of the invention. For example, the Head Support and Coil Alignment Unit 30 of the invention could be modified to target any other anatomical landmark of the patient that also produces a repeatable position relative to internal anatomy. Also, rather than searching for the MT position for use in finding a treatment position for treating depression, the system of the invention may be used to find the Wernicke's Area for treating schizophrenia or finding other treatment positions for other central nervous system disorders responsive to TMS treatments.
Also, those skilled in the art will appreciate that the multi-axis support gantry of the invention may be replaced by a suitable ball and socket arrangement that allows precise control of three-dimensional movements of the coil assembly.
Accordingly, any such modifications are intended to be included within the scope of this invention as defined by the following exemplary claims.
Number | Name | Date | Kind |
---|---|---|---|
3683923 | Anderson | Aug 1972 | A |
4712558 | Kidd et al. | Dec 1987 | A |
4807618 | Auchinleck et al. | Feb 1989 | A |
4995395 | Ilmoniemi et al. | Feb 1991 | A |
5097833 | Campos | Mar 1992 | A |
5116304 | Cadwell | May 1992 | A |
5299569 | Wernicke et al. | Apr 1994 | A |
5370117 | McLaurin, Jr. | Dec 1994 | A |
5655534 | Ilmoniemi | Aug 1997 | A |
5707334 | Young | Jan 1998 | A |
5769778 | Abrams et al. | Jun 1998 | A |
5813970 | Abrams et al. | Sep 1998 | A |
5828770 | Leis et al. | Oct 1998 | A |
5855582 | Gildenberg | Jan 1999 | A |
5916189 | Sullenperger et al. | Jun 1999 | A |
5923417 | Leis | Jul 1999 | A |
6061644 | Leis | May 2000 | A |
6066084 | Edrich et al. | May 2000 | A |
6117066 | Abrams et al. | Sep 2000 | A |
6148823 | Hastings | Nov 2000 | A |
6169963 | Markov | Jan 2001 | B1 |
6179771 | Mueller | Jan 2001 | B1 |
6198958 | Ives et al. | Mar 2001 | B1 |
6241670 | Nambu | Jun 2001 | B1 |
6253109 | Gielen | Jun 2001 | B1 |
6256531 | Ilmoniemi et al. | Jul 2001 | B1 |
6266556 | Ives et al. | Jul 2001 | B1 |
6288785 | Frantz et al. | Sep 2001 | B1 |
6366814 | Boveja et al. | Apr 2002 | B1 |
6389318 | Zarinetchi et al. | May 2002 | B1 |
6402678 | Fischell et al. | Jun 2002 | B1 |
6418345 | Tepper et al. | Jul 2002 | B1 |
6463328 | John | Oct 2002 | B1 |
6480743 | Kirkpatrick et al. | Nov 2002 | B1 |
6484059 | Gielen | Nov 2002 | B2 |
6488617 | Katz | Dec 2002 | B1 |
6497648 | Rey | Dec 2002 | B1 |
6503187 | Ilmoniemi et al. | Jan 2003 | B1 |
6516213 | Nevo | Feb 2003 | B1 |
6516288 | Bagne | Feb 2003 | B2 |
6537197 | Ruohonen et al. | Mar 2003 | B1 |
6551233 | Perreault et al. | Apr 2003 | B2 |
6553326 | Kirsch et al. | Apr 2003 | B1 |
6560490 | Grill et al. | May 2003 | B2 |
6567702 | Nekhendzy et al. | May 2003 | B1 |
6571123 | Ives et al. | May 2003 | B2 |
6572528 | Rohan et al. | Jun 2003 | B2 |
6625563 | Kirsch et al. | Sep 2003 | B2 |
6827681 | Tanner et al. | Dec 2004 | B2 |
6830544 | Tanner | Dec 2004 | B2 |
6849040 | Ruohonen et al. | Feb 2005 | B2 |
6926660 | Miller | Aug 2005 | B2 |
6978179 | Flagg et al. | Dec 2005 | B1 |
7087008 | Fox et al. | Aug 2006 | B2 |
7104947 | Riehl | Sep 2006 | B2 |
7120954 | Traut et al. | Oct 2006 | B2 |
20020013612 | Whitehurst | Jan 2002 | A1 |
20020087201 | Firlik et al. | Jul 2002 | A1 |
20020091419 | Firlik et al. | Jul 2002 | A1 |
20020103515 | Davey et al. | Aug 2002 | A1 |
20020123780 | Grill et al. | Sep 2002 | A1 |
20020160436 | Markov et al. | Oct 2002 | A1 |
20020169355 | Rohan et al. | Nov 2002 | A1 |
20030004392 | Tanner et al. | Jan 2003 | A1 |
20030023159 | Tanner | Jan 2003 | A1 |
20030028072 | Fischell et al. | Feb 2003 | A1 |
20030050527 | Fox et al. | Mar 2003 | A1 |
20030065243 | Tanner | Apr 2003 | A1 |
20030073899 | Ruohonen et al. | Apr 2003 | A1 |
20030074032 | Gliner | Apr 2003 | A1 |
20030082507 | Stypulkowski | May 2003 | A1 |
20030088274 | Gliner et al. | May 2003 | A1 |
20030097161 | Firlik et al. | May 2003 | A1 |
20030125786 | Gliner et al. | Jul 2003 | A1 |
20030130706 | Sheffield et al. | Jul 2003 | A1 |
20040010177 | Rohan et al. | Jan 2004 | A1 |
20040016057 | Traut et al. | Jan 2004 | A1 |
20040019370 | Gliner et al. | Jan 2004 | A1 |
20040077921 | Becker et al. | Apr 2004 | A1 |
20040127942 | Yomtov et al. | Jul 2004 | A1 |
20040153129 | Pless et al. | Aug 2004 | A1 |
20050021104 | DiLorenzo | Jan 2005 | A1 |
20050049486 | Urquhart et al. | Mar 2005 | A1 |
20050124848 | Holzner | Jun 2005 | A1 |
20050148808 | Cameron et al. | Jul 2005 | A1 |
20050216071 | Devlin et al. | Sep 2005 | A1 |
20050228209 | Schneider et al. | Oct 2005 | A1 |
20050234286 | Riehl et al. | Oct 2005 | A1 |
20050256539 | George et al. | Nov 2005 | A1 |
20060161039 | Juliana et al. | Jul 2006 | A1 |
20060287566 | Zangen et al. | Dec 2006 | A1 |
Number | Date | Country |
---|---|---|
998958 | Dec 2000 | EP |
1273320 | Jan 2003 | EP |
63-234962 | Sep 1988 | JP |
7-67972 | Mar 1995 | JP |
8-24298 | Jan 1996 | JP |
8-71168 | Mar 1996 | JP |
11-178809 | Jul 1999 | JP |
2002-538885 | Nov 2002 | JP |
2003-126056 | May 2003 | JP |
2003-180649 | Jul 2003 | JP |
2006-520671 | Sep 2006 | JP |
2007-508853 | Apr 2007 | JP |
2007-526027 | Sep 2007 | JP |
2008-505662 | Feb 2008 | JP |
2008-528108 | Jul 2008 | JP |
WO 1999064884 | Dec 1999 | WO |
WO 200054690 | Sep 2000 | WO |
WO 2000074777 | Dec 2000 | WO |
WO 2001012236 | Feb 2001 | WO |
WO 2001028622 | Apr 2001 | WO |
WO 200197906 | Dec 2001 | WO |
WO 2002009811 | Feb 2002 | WO |
WO 2002031604 | Apr 2002 | WO |
WO 2002032504 | Apr 2002 | WO |
WO 2002072194 | Sep 2002 | WO |
WO 2002085449 | Oct 2002 | WO |
WO 2002085454 | Oct 2002 | WO |
WO 2002089902 | Nov 2002 | WO |
WO 2002094997 | Nov 2002 | WO |
WO 2003035163 | May 2003 | WO |
WO 2003082405 | Oct 2003 | WO |
2003098268 | Nov 2003 | WO |
WO 2003090604 | Nov 2003 | WO |
WO 2004080526 | Sep 2004 | WO |
WO 2004100765 | Nov 2004 | WO |
WO 2005000401 | Jan 2005 | WO |
WO 2005065768 | Jul 2005 | WO |
WO 2005067610 | Jul 2005 | WO |
Entry |
---|
George et al. in “Daily Repetitive Transcranial Magnetic Stimulation (rTMS) Improves Mood in Depression,” NeuroReport, vol. 6, No. 14, Oct. 1995, pp. 1853-1856. |
Pascual-Leone et al. in “Rapid-Rate Transcranial Magnetic Stimulation of Left Dorsolateral Prefrontal Cortex in Drug-Resistant Depression,” The Lancet, vol. 348, Jul. 27, 1996, pp. 233-237. |
Wassermann, E.M., “Repetitive Transcranial Magnetic Stimulation: An Introduction and Overview”, CNS Spectrums, The International Journal of Neuropsychiatric Medicine, Jan. 1997, 7 pages. |
Hess et al., “Magnetic Stimulation of the Human Brain: Influence of Size and Shape of the Stimulating Coil”, Motor Disturbances II, A Selection of Papers Delivered at the 2nd Congress of the International Medical Society of Motor Disturbances Held at, Rome, Italy, Jun. 2-4, 1988, Published in Sep. 1990, Academic Press, 3, 31-42. |
Baudewig et al., “Functional MRI of Cortical Activations Induced by Transcranial Magnetic Stimulation (TMS)”, Brain Imaging-Neuro Report, vol. 12, No. 16, Nov. 16, 2001, 3543-3548. |
Bohning et al., “A Combined TMS/fMRI Study of Intensity-Dependant TMS over Motor Cortex”, Society of Biological Psychiatry, vol. 45, No. 4, Feb. 15, 1999, 385-394. |
Bohning et al., “A TMS Coil Positioning/Holding System for MR Image-Guided TMSInter leaved with fMRI”, Clinical Neurophysiology, vol. 114, No. 11, Nov. 2003, 2210-2219. |
Bohning et al., “BOLD-fMRI Response to Single-Pulse Transcranial Magnetic Stimulation (TMS)”, Journal of Magnetic Resonance Imaging, vol. 11, No. 6, Jun. 2000, 569-574. |
George et al., “A Controlled Trial of Daily Left Prefrontal Cortex TMS for Treating Depression”, Society of Biological Psychiatry, vol. 48, No. 10, Nov. 15, 2000, 962-970. |
Grafman, J., “TMS as a Primary Brain Mapping Tool”, Transcranial Magnetic Stimulation in Neuropsychiatry, First Edition, American Psychiatric Press, 2000, 115-140. |
Lisanby et al., “Sham TMS: Intracerebral Measurement of the Induced Electrical Field and the Induction of Motor-Evoked Potentials”, Society of Biological Psychiatry, vol. 49, No. 5, Mar. 1, 2001, 460-463. |
Loo et al., “Transcranial Magnetic Stimulation (TMS) in Controlled Treatment Studies: Are Some “Sham” Forms Active?”, Society of Biological Psychiatry, vol. 47, No. 4, Feb. 15, 2000, 325-331. |
Lorberbaum, J. P., “Safety Concerns of TMS”, Transcranial Magnetic Stimulation in Neuropsychiatry, First Edition, American Psychiatric Press, 2000, 141-161. |
Nahas et al., “Left Prefrontal Transcranial Magnetic Stimulation (TMS) Treatment of Depression in Bipolar Affective Disorder: A Pilot Study of Acute Safety and Efficacy”, Bipolar Disorders, vol. 5, No. 1, Feb. 2003, 40-47. |
Nahas et al., “Unilateral Left Prefrontal Transcranial Magnetic Stimulation (TMS) Produces Intensity-Dependent Bilateral Effects as Measured by Interleaved BOLD fMRI”, Society of Biological Psychiatry, vol. 50, No. 9, Nov. 1, 2001, 712-720. |
Pridmore, S., “Substitution of Rapid Transcranial Magnetic Stimulation Treatments for Electroconvulsive Therapy Treatments in a Course of Electroconvulsive Therapy”, Depression and Anxiety, vol. 12, No. 3, 2000, 118-123. |
Ruohonen, J., “Electroencephalography Combined with TMS”, BioMag Laboratory, Helsinki University Central Hospital, Oct. 6, 1999, 22 pages. |
Number | Date | Country | |
---|---|---|---|
20090227830 A1 | Sep 2009 | US |